Sign In
Buy APM
$1.09
+0.114 (+11.68%)
At Close: Jun 03, 2026
Aptorum Group Limited Announces Results of 2019 Annual General Meeting
01:00pm, Friday, 15'th Nov 2019
Aptorum Group Limited a biopharmaceutical company focused on the development of novel therapeutics to address certain global unmet medical needs, announced today the results of its 2019 Annual General
Aptorum Group Limited's (NASDAQ:APM) Single Biggest Risk For Investors
12:10pm, Thursday, 19'th Sep 2019
Trailing twelve-month data shows us that Aptorum Group Limited's (NASDAQ:APM) earnings loss has accumulated to...
APM: Aptorum Focused on Development of Diseases with Significant Global Unmet Needs
03:05pm, Wednesday, 26'th Jun 2019
Aptorum Group Limited (APM) went public through an initial public offering which closed in December 2018 and raised $12.0M (gross) from the sale of 761k common shares. The shares were added to the Mo
